95 related articles for article (PubMed ID: 23424206)
1. N-acetylcysteine prevents doxorubucine-induced cardiotoxicity in rats.
Arica V; Demir İH; Tutanc M; Basarslan F; Arica S; Karcoıglu M; Öztürk H; Nacar A
Hum Exp Toxicol; 2013 Jun; 32(6):655-61. PubMed ID: 23424206
[TBL] [Abstract][Full Text] [Related]
2. Effects of histidine and N-acetylcysteine on doxorubicin-induced cardiomyopathy in rats.
Farshid AA; Tamaddonfard E; Simaee N; Mansouri S; Najafi S; Asri-Rezaee S; Alavi H
Cardiovasc Toxicol; 2014 Jun; 14(2):153-61. PubMed ID: 24343415
[TBL] [Abstract][Full Text] [Related]
3. N-acetylcysteine modulates doxorubicin-induced oxidative stress and antioxidant vitamin concentrations in liver of rats.
Koçkar MC; Nazıroğlu M; Celik O; Tola HT; Bayram D; Koyu A
Cell Biochem Funct; 2010 Dec; 28(8):673-7. PubMed ID: 21104935
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicin: role of aminoguanidine.
Abd El-Gawad HM; El-Sawalhi MM
J Biochem Mol Toxicol; 2004; 18(2):69-77. PubMed ID: 15122648
[TBL] [Abstract][Full Text] [Related]
5. Effect of N-acetylcysteine on carboplatin-induced ototoxicity and nitric oxide levels in a rat model.
Okur E; Kilinc M; Yildirim I; Kilic MA; Tolun FI
Laryngoscope; 2007 Dec; 117(12):2183-6. PubMed ID: 17909450
[TBL] [Abstract][Full Text] [Related]
6. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
Mohamed HE; Asker ME; Ali SI; el-Fattah TM
J Pharm Pharmacol; 2004 Jun; 56(6):757-68. PubMed ID: 15231041
[TBL] [Abstract][Full Text] [Related]
7. How to protect doxorubicin-induced cardiomyopathy in male albino rats?
Shaker O; Sourour DA
J Cardiovasc Pharmacol; 2010 Mar; 55(3):262-8. PubMed ID: 20051877
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of N-acetylcysteine, caffeic acid and vitamin E on doxorubicin hepatotoxicity.
Gokcimen A; Cim A; Tola HT; Bayram D; Kocak A; Ozgüner F; Ayata A
Hum Exp Toxicol; 2007 Jun; 26(6):519-25. PubMed ID: 17698947
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of ivabradine on hemodynamic parameters and cardiotoxicity induced by doxorubicin treatment in rat.
Colak MC; Parlakpinar H; Tasdemir S; Samdanci E; Kose E; Polat A; Sarihan E; Acet A
Hum Exp Toxicol; 2012 Sep; 31(9):945-54. PubMed ID: 22354086
[TBL] [Abstract][Full Text] [Related]
10. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
Saad SY; Najjar TA; Alashari M
J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
[TBL] [Abstract][Full Text] [Related]
11. Detrimental effects of N-acetylcysteine plus desferoxamine combination in an experimental nephrotic syndrome model.
Bulucu F; Oktenli C; Kenar L; Koc B; Ocal R; Karadurmus N; Inal V; Yamanel L; Sanisoglu YS; Aydin A
Int J Toxicol; 2007; 26(6):525-32. PubMed ID: 18066968
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by oral N-acetylcysteine of doxorubicin-induced clastogenicity and alopecia, and prevention of primary tumors and lung micrometastases in mice.
D'Agostini F; Bagnasco M; Giunciuglio D; Albini A; De Flora S
Int J Oncol; 1998 Aug; 13(2):217-24. PubMed ID: 9664114
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of acute lung injury following lower limb ischemia/reperfusion: the pharmacological approach.
Koksal C; Bozkurt AK; Ustundag N; Konukoglu D; Musellim B; Sirin G; Cortelekoglu T; Sayin AG
J Cardiovasc Surg (Torino); 2006 Aug; 47(4):445-9. PubMed ID: 16953164
[TBL] [Abstract][Full Text] [Related]
14. The cardioprotective effects of an antiemetic drug, tropisetron, on cardiomyopathy related to doxorubicin.
Alimoradi H; Barzegar-Fallah A; Hassanzadeh G; Mohammadi-Rick S; Asadi F; Delfan B; Abbasi A; Dehpour AR
Cardiovasc Toxicol; 2012 Dec; 12(4):318-25. PubMed ID: 22744232
[TBL] [Abstract][Full Text] [Related]
15. Ellagic acid, a natural polyphenol protects rat peripheral blood lymphocytes against nicotine-induced cellular and DNA damage in vitro: with the comparison of N-acetylcysteine.
Sudheer AR; Muthukumaran S; Devipriya N; Menon VP
Toxicology; 2007 Jan; 230(1):11-21. PubMed ID: 17188416
[TBL] [Abstract][Full Text] [Related]
16. The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice.
Bruynzeel AM; Mul PP; Berkhof J; Bast A; Niessen HW; van der Vijgh WJ
Cancer Chemother Pharmacol; 2006 Nov; 58(5):699-702. PubMed ID: 16565833
[TBL] [Abstract][Full Text] [Related]
17. N-acetylcysteine offers cardioprotection by decreasing cardiac lipid hydroperoxides and 8-isoprostane level in isoproterenol-induced cardiotoxicity in rats.
Haleagrahara N; Julian V; Chakravarthi S
Cardiovasc Toxicol; 2011 Dec; 11(4):373-81. PubMed ID: 21796404
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of N-acetylcysteine and selenium against doxorubicin toxicity in rats.
Park ES; Kim SD; Lee MH; Lee HS; Lee IS; Sung JK; Yoon YS
J Vet Sci; 2003 Aug; 4(2):129-36. PubMed ID: 14610365
[TBL] [Abstract][Full Text] [Related]
19. DMPS and N-acetylcysteine induced renal toxicity in mice exposed to mercury.
Brandão R; Santos FW; Zeni G; Rocha JB; Nogueira CW
Biometals; 2006 Aug; 19(4):389-98. PubMed ID: 16841248
[TBL] [Abstract][Full Text] [Related]
20. Effect of N-acetylcysteine on markers of skeletal muscle injury after fatiguing contractile activity.
Pinheiro CH; Vitzel KF; Curi R
Scand J Med Sci Sports; 2012 Feb; 22(1):24-33. PubMed ID: 20673252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
